![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 05, 2017 7:40:14 PM
"No, that is not correct. I don’t remember the exact timeline, but we updated the clinical trials website late last year or early this year. We updated the status to indicate the trial is now closed at all sites. Until late last year we had a single site remaining open in the UK. Analysis of the data will commence when we get the financing we are seeking finalized. At that time we’ll provide the investigators with the data and a draft of the conclusions for them to review and circulate among the authors. I am sure they will seek publication in a journal, a process that takes 6-9 months. In order to get published, the results of MORDIS cannot be released in any other format.
We are finishing up the draft of the K which will be supplied to our auditors for their review. Our auditors will be on site here in San Diego, make their final comments, review those comments with our board’s audit committee and released before the end of March.
Hope this information is helpful to you.
Regards.
Mike"
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM